Showing results (111-120 of 281) with videos related to

Sort By:
Pageof 29
Exploratory Research in Clinical and Social Pharmacy|April 18, 2022
Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review RecipientsXiaobei Dong, Chi Chun Steve Tsang, Jim Y Wan, et al.
Journal of the American Heart Association|May 9, 2023
Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020Catherine G Derington, Adam P Bress, Jennifer S Herrick, et al.
Journal of the American Geriatrics Society|January 24, 2019
Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic GroupsChristina A Spivey, Yanru Qiao, Junling Wang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Hypertension control among newly treated patients before and after publication of the main ALLHAT results and JNC 7 guidelinesMarie Krousel-Wood, Paul Muntner, April Carson, et al.
Annals of Clinical and Translational Neurology|January 19, 2019
Lowering systolic blood pressure does not increase stroke risk: an analysis of the SPRINT and ACCORD trial dataEllen C O'Conor, Jiajing Wang, Kyla D Gibney, et al.
Hypertension (Dallas, Tex. : 1979)|May 25, 2016
The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialIan M Kronish, Amy I Lynch, Suzanne Oparil, et al.
Diabetes Care|June 23, 2012
Intensive blood pressure treatment does not improve cardiovascular outcomes in centrally obese hypertensive individuals with diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure TrialJoshua I Barzilay, Annie G Howard, Gregory W Evans, et al.
Clinical Cardiology|April 14, 2018
Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndromeMatthew A Cavender, William B White, Yuyin Liu, et al.
Cardiovascular Diabetology|November 26, 2020
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysisGilles R Dagenais, Lars Rydén, Lawrence A Leiter, et al.
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
The role of noninvasive hemodynamic monitoring in the evaluation and treatment of hypertensionCarlos M Ferrario, Jan Basile, William Bestermann, et al.
Pageof 29